“Health-Related Quality of Life in Patients with Metastatic Basal Cell Carcinoma Treated with Cemiplimab: Analysis of a Phase 2 Open-Label Clinical Trial” (2024) SKIN The Journal of Cutaneous Medicine, 8(1), p. s337. doi:10.25251/skin.8.supp.337.